[Research on association of BDNF gene Val66Met polymorphism with efficacy of antidepressants and plasma BDNF level].
Lists
Only you see this
Abstract
No association has been found between the efficacy of venlafaxine or paroxetine and the BDNF Val66Met polymorphism. The BDNF level of patients with depression is significantly lower than healthy controls on the baseline, and can be enhanced with the treatment. Particularly, the BDNF level in patients who achieved remission after the treatment of venlafaxine can rise to normal. The level of BDNF has certain value in the forecasting of efficacy in the anti-depression therapy. BDNF level is not associated with the Val66Met polymorphism of the BDNF gene.
BibTeX
@inproceedings{shen2014research,
author = {Xinhua Shen and Mincai Qian and Yonggui Yuan and Jushui Sun and Hua Zhong and Jianhong Yang and Min Lin and Liang Li and Tiefeng Guan and Zhongxia Shen},
title = {{[Research on association of BDNF gene Val66Met polymorphism with efficacy of antidepressants and plasma BDNF level].}},
booktitle = {PubMed},
year = {2014},
doi = {10.3760/cma.j.issn.1003-9406.2014.02.015},
}Loading related content...